Profile of extended-release oxycodone/acetaminophen for acute pain

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Profile of extended-release oxycodone/acetaminophen for acute pain

This article provides a historical and pharmacological overview of a new opioid analgesic that boasts an extended-release (ER) formulation designed to provide both immediate and prolonged analgesia for up to 12 hours in patients who are experiencing acute pain. This novel medication, ER oxycodone/acetaminophen, competes with current US Food and Drug Administration (FDA)-approved opioid formulat...

متن کامل

Cyclobenzaprine extended release for acute low back and neck pain

Low back pain and neck pain are major public health problems in the USA [1]. In a 3‐month prevalence study conducted across the USA, more than 34 million (17%) adults reported low back pain alone, 9 million (4%) reported neck pain alone and 19 million (9%) reported both low back pain and neck pain, resulting in a 3‐month combined prevalence of 31% of adults [1]. Studies conducted elsewhere repo...

متن کامل

Tapentadol extended-release for treatment of chronic pain: a review

Tapentadol is a centrally acting analgesic with a dual mechanism of action of mu receptor agonism and norepinephrine reuptake inhibition. Tapentadol immediate-release is approved by the US Food and Drug Administration for the management of moderate-to-severe acute pain. It was developed to decrease the intolerability issue associated with opioids. Tapentadol extended-release has a 12-hour durat...

متن کامل

Clinical application of extended-release hydromorphone for pain management

Hydromorphone is a semi-synthetic μ-agonist commercially available in oral, rectal and injectable formulations for the control of acute and chronic pain [1]. Hydromorphone is typically used for moderate-to-severe pain, and is an effective alternative to morphine [1]. Like other μ-agonists in the opioid family there is no ceiling effect for hydromorphone, and cross-tolerance with other opioids i...

متن کامل

Safety of liposome extended-release bupivacaine for postoperative pain control

BACKGROUND Ideal postoperative pain management requires a multidisciplinary approach in combination with a variety of dosage regimens. Approximately 21-30% of patients experience moderate to severe pain in the postoperative period, which may have a significant impact on recovery rate, standard of living, psychological health, and postoperative complications. OBJECTIVE Analysis of the incidenc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Pain Research

سال: 2015

ISSN: 1178-7090

DOI: 10.2147/jpr.s73567